Abstract B122: 2 for 1: Targeting tumor-associated macrophages and cancer cells with a novel MERTK-targeting antibody-drug conjugate (ADC)
Year: 2023
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4389227525
